SCHEMBL18830326

SCHEMBL18830326

Cc1ccc2cc(-n3nnc4cnc(NC5CCCC5)nc43)cnc2c1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 3/20 0.55
▸ GSK3B P49841 3/20 0.55
▸ MAPK6 Q16659 10/20 0.53
▸ CDK4 P11802 1/20 0.42
▸ CCND1 P24385 1/20 0.42
▸ CCND2 P30279 1/20 0.42
▸ CCND3 P30281 1/20 0.42
▸ MAPK8 P45983 2/20 0.41
▸ MAPK9 P45984 2/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ AURKA O14965 1/20 0.40
▸ TP53 P04637 4/20 0.40
▸ LMNA P02545 2/20 0.40
▸ MAPK10 P53779 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18830045 0.85 MAPK6 (0.54) GSK3AGSK3BMAPK6CDK4CCND1
SCHEMBL18830178 0.85 MAPK6 (0.53) GSK3AGSK3BMAPK6CDK4CCND1
SCHEMBL16011895 0.84 MAPK6 (0.63) GSK3AGSK3BMAPK6AURKA
SCHEMBL16011896 0.84 MAPK6 (0.63) GSK3AGSK3BMAPK6AURKA
SCHEMBL18830239 0.82 GSK3A (0.60) GSK3AGSK3BMAPK6CDK4CCND1
SCHEMBL18830319 0.81 MAPK6 (0.54) GSK3AGSK3BMAPK6CDK4CCND1
SCHEMBL18830321 0.81 GSK3A (0.55) GSK3AGSK3BMAPK6CDK4CCND1
SCHEMBL18830216 0.80 GSK3A (0.57) GSK3AGSK3BMAPK6MAPK8MAPK9
Carbamic Acid SCHEMBL18813041 0.80 MAPK6 (0.56) GSK3AGSK3BMAPK6CDK4CCND1
SCHEMBL18830129 0.80 MAPK6 (0.52) GSK3AGSK3BMAPK6CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP disclosed
Send feedback